Cargando…

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy

BACKGROUND: Previously, we had shown that persons infected with human T-cell lymphoma leukemia virus 1 or 2 (HTLV-1 or 2) had an increased prevalence of antibodies to a peptide in the Pol protein of the retrovirus HERV-K10, homologous to a peptide in HTLV gp21 envelope protein. The prevalence rate w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perzova, Raisa, Graziano, Elliot, Sanghi, Swathi, Welch, Caitlin, Benz, Patricia, Abbott, Lynn, Lalone, Danielle, Glaser, Jordan, Loughran, Thomas, Sheremata, William, Poiesz, Bernard J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878045/ https://www.ncbi.nlm.nih.gov/pubmed/24365054 http://dx.doi.org/10.1186/1743-422X-10-360

Ejemplares similares

Is MMTV associated with human breast cancer? Maybe, but probably not
por: Perzova, Raisa, et al.
Publicado: (2017)

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity
por: Brudek, Tomasz, et al.
Publicado: (2009)

The complete genomic sequence of an in vivo low replicating BLV strain
por: Dube, Syamalima, et al.
Publicado: (2009)

Anti-HERV-W(Env) antibodies are correlated with seroreactivity against Mycobacterium avium subsp. paratuberculosis in children and youths at T1D risk
por: Niegowska, Magdalena, et al.
Publicado: (2019)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Cardiovascular risk profile in patients with myelopathy associated with HTLV-1()
por: Prado, Fabio Luís Silva do, et al.
Publicado: (2017)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
por: Buell, Kevin G., et al.
Publicado: (2016)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Patrício, Naiane Araújo, et al.
Publicado: (2020)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
por: Liberato de Matos, Sheila N. F., et al.
Publicado: (2022)

Activation of LTRs from Different Human Endogenous Retrovirus (HERV) Families by the HTLV-1 Tax Protein and T-Cell Activators
por: Toufaily, Chirine, et al.
Publicado: (2011)

Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy
por: Bastos, Rafael HC, et al.
Publicado: (2014)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines
por: DUBE, SYAMALIMA, et al.
Publicado: (2016)

Seroreactivity to Dirofilaria antigens in people from different areas of Serbia
por: Tasić-Otašević, Suzana A, et al.
Publicado: (2014)

Seroreactivity to Q Fever Among Slaughterhouse Workers in South Korea
por: Chu, Hyuk, et al.
Publicado: (2017)

Seroreactivity against Marburg or related filoviruses in West and Central Africa
por: Steffen, Imke, et al.
Publicado: (2020)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy
por: Adonis, A, et al.
Publicado: (2014)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
por: Martin, Fabiola, et al.
Publicado: (2014)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats
Publicado: (1992)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Baratella, Marco, et al.
Publicado: (2017)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

False positive seroreactivity to brucellosis in tuberculosis patients: a prevalence study
por: Varshochi, Mojtaba, et al.
Publicado: (2011)

Borrelia miyamotoi sensu lato Seroreactivity and Seroprevalence in the Northeastern United States
por: Krause, Peter J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mujanqvket4nh00km77lm0sf3e